Bio-Rad Laboratories (Bio-Rad Laboratories) Interest Coverage

: 7.71 (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Bio-Rad Laboratories's Operating Income for the three months ended in Dec. 2023 was $95 Mil. Bio-Rad Laboratories's Interest Expense for the three months ended in Dec. 2023 was $-12 Mil. Bio-Rad Laboratories's interest coverage for the quarter that ended in Dec. 2023 was 7.71. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Bio-Rad Laboratories's Interest Coverage or its related term are showing as below:

BIO.B' s Interest Coverage Range Over the Past 10 Years
Min: 5.05 Med: 7.79 Max: 322.59
Current: 6.83

BIO.B's Interest Coverage is ranked worse than
72.77% of 426 companies
in the Medical Devices & Instruments industry
Industry Median: 19.84 vs BIO.B: 6.83

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bio-Rad Laboratories Interest Coverage Historical Data

The historical data trend for Bio-Rad Laboratories's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Bio-Rad Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Coverage

9.81

19.27

322.59

12.47

6.83

Bio-Rad Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Coverage																9.52	5.02	7.26	7.34	7.71

Competitive Comparison

For the Medical Devices subindustry, Bio-Rad Laboratories's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio-Rad Laboratories Interest Coverage Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's Interest Coverage falls into.

Bio-Rad Laboratories Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bio-Rad Laboratories's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, Bio-Rad Laboratories's Interest Expense was $-49 Mil. Its Operating Income was $338 Mil. And its Long-Term Debt & Capital Lease Obligation was $1,365 Mil.

Interest Coverage	=	-1	*	Operating Income (A: Dec. 2023 )	/	Interest Expense (A: Dec. 2023 )
	=	-1	*	337.796	/	-49.439
	=	6.83

Bio-Rad Laboratories's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Here, for the three months ended in Dec. 2023, Bio-Rad Laboratories's Interest Expense was $-12 Mil. Its Operating Income was $95 Mil. And its Long-Term Debt & Capital Lease Obligation was $1,365 Mil.

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	95.317	/	-12.361
	=	7.71

The higher the ratio, the stronger the company's Financial Strength is.

Bio-Rad Laboratories (NYSE:BIO.B) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Bio-Rad Laboratories Interest Coverage Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Rad Laboratories (Bio-Rad Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (NYSE:BIO.B) » Definitions » Interest Coverage

Comparable Companies

Traded in Other Exchanges

BIO:USA BUWA:Germany

Address

1000 Alfred Nobel Drive, Hercules, CA, USA, 94547

Website

https://www.bio-rad.com

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.